In silico characterization of immunogenic epitopes presented by HLA-Cw*0401.
BACKGROUND
HLA-C locus products are poorly understood in part due to their low expression at the cell surface. Recent data indicate that these molecules serve as major restriction elements for human immunodeficiency virus type 1 (HIV-1) cytotoxic T lymphocyte (CTL) epitopes. We report here a structure-based technique for the prediction of peptides binding to Cw*0401. The models were rigorously trained, tested and validated using experimentally verified Cw*0401 binding and non-binding peptides obtained from biochemical studies. A new scoring scheme facilitates the identification of immunological hot spots within antigens, based on the sum of predicted binding energies of the top four binders within a window of 30 amino acids.


RESULTS
High predictivity is achieved when tested on the training (r(2) = 0.88, s = 3.56 kJ/mol, q(2) = 0.84, s(press) = 5.18 kJ/mol) and test (A(ROC) = 0.93) datasets. Characterization of the predicted Cw*0401 binding sequences indicate that amino acids at key anchor positions share common physico-chemical properties which correlate well with existing experimental studies.


CONCLUSIONS
The analysis of predicted Cw*0401-binding peptides showed that anchor residues may not be restrictive and the Cw*0401 binding pockets may possibly accommodate a wide variety of peptides with common physico-chemical properties. The potential Cw*0401-specific T-cell epitope repertoires for HIV-1 p24(gag) and gp160(gag) glycoproteins are well distributed throughout both glycoproteins, with thirteen and nine immunological hot spots for HIV-1 p24(gag) and gp160(gag) glycoproteins respectively. These findings provide new insights into HLA-C peptide selectivity, indicating that pre-selection of candidate HLA-C peptides may occur at the TAP level, prior to peptide loading in the endoplasmic reticulum.
Tong
Joo Chuan
JC
Institute for Infocomm Research, 21 Heng Mui Keng Terrace, 119613, Singapore. jctong@i2r.a-star.edu.sg
Zhang
Zong Hong
ZH
August
J Thomas
JT
Brusic
Vladimir
V
Tan
Tin Wee
TW
Ranganathan
Shoba
S
Immunol Lett. 1997 Mar;55(3):145-9
9161880
Tissue Antigens. 2000 Nov;56(5):392-404
11144287
Eur J Immunol. 1988 May;18(5):801-10
2967765
J Virol. 1993 Jan;67(1):438-45
7677956
Bioinformatics. 2006 May 15;22(10):1232-8
16510499
Immunome Res. 2006;2:1
16426456
Immunogenetics. 1999 Nov;50(3-4):213-9
10602881
Methods. 2004 Dec;34(4):436-43
15542369
J Med Chem. 1999 Nov 4;42(22):4650-8
10579827
Nucleic Acids Res. 2007 Jan;35(Database issue):D193-7
17142230
J Exp Med. 1999 Jul 5;190(1):113-23
10429675
J Virol. 1991 Aug;65(8):4051-6
1712857
Eur J Immunol. 1977 Aug;7(8):580-5
332508
Proc Natl Acad Sci U S A. 1988 Aug;85(15):5664-8
2840670
Protein Sci. 2004 Sep;13(9):2523-32
15322290
J Immunol. 1998 Jan 1;160(1):171-9
9551969
J Exp Med. 1995 Jun 1;181(6):2085-95
7760000
BMC Bioinformatics. 2006;7 Suppl 5:S7
17254312
J Immunol. 1995 Jan 1;154(1):247-59
7527812
J Exp Med. 1997 Apr 21;185(8):1523-8
9126935
Bioinformatics. 2004 Aug 4;20 Suppl 1:i297-302
15262812
Immunogenetics. 2003 Jun;55(3):172-6
12750860
Trends Biochem Sci. 1995 Sep;20(9):374
7482707
Immunogenetics. 2007 Jan;59(1):25-35
17119951